Organ-on-a-Chip Market

The Organ-on-a-Chip market consists of microfluidic devices lined with living human cells that simulate the structure and function of human organs. These platforms are primarily used by pharmaceutical and biotechnology companies, as well as academic and research institutions, for more realistic and controlled research. Key growth drivers include the need to improve the efficiency of drug discovery, reduce the high failure rate of clinical trials, and respond to ethical and regulatory pressures for alternatives to animal testing.